Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 325 of 2228 entries
View as:

Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00824408 Org: User:
Start: 03/31/09 End: 08/31/15 Due: 08/31/16

Cardiovascular Function in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03055988 Org: User:
Start: 03/29/17 End: 03/26/18 Due: 03/26/19

Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02172430 Org: User:
Start: 09/30/00 End: - Due: -

A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems

Phase: N/A Priority: Normal
NCT ID: NCT05731895 Org: User:
Start: 03/08/23 End: 12/11/23 Due: 12/11/24

Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02257008 Org: User:
Start: 03/31/03 End: - Due: -

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Phase: N/A Priority: Normal
NCT ID: NCT00933205 Org: User:
Start: 05/31/04 End: - Due: -

Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)

Phase: N/A Priority: Normal
NCT ID: NCT01703286 Org: User:
Start: 10/31/12 End: 01/31/14 Due: 01/31/15

A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body

Phase: N/A Priority: Normal
NCT ID: NCT04590937 Org: User:
Start: 10/20/20 End: 01/11/21 Due: 01/11/22

Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02172300 Org: User:
Start: 06/30/99 End: - Due: -

Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00935220 Org: User:
Start: 06/30/09 End: - Due: -

Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea

Phase: N/A Priority: Normal
NCT ID: NCT02183025 Org: User:
Start: 01/31/98 End: - Due: -

A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05896384 Org: User:
Start: 12/21/23 End: 03/26/25 Due: 03/26/26

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01533935 Org: User:
Start: 02/29/12 End: 11/30/13 Due: 11/30/14

Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01809262 Org: User:
Start: 12/31/05 End: 11/30/06 Due: 11/30/07

Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation

Phase: N/A Priority: Normal
NCT ID: NCT02172521 Org: User:
Start: 01/31/06 End: - Due: -

Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02273440 Org: User:
Start: 05/31/00 End: - Due: -

Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01431274 Org: User:
Start: 09/30/11 End: 09/30/13 Due: 09/30/14

Olmutinib (BI 1482694) ADME Study

Phase: N/A Priority: Normal
NCT ID: NCT02722161 Org: User:
Start: 04/30/16 End: 06/30/16 Due: 06/30/17

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL

Phase: N/A Priority: Normal
NCT ID: NCT01587417 Org: User:
Start: 04/30/12 End: 10/31/12 Due: 10/31/13

Study to Explore Pharmacokinetics and Pharmacodynamics of a Single Rising Dose of BI 135585 XX

Phase: N/A Priority: Normal
NCT ID: NCT01652742 Org: User:
Start: 07/31/12 End: 09/30/12 Due: 09/30/13

Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003328 Org: User:
Start: 12/31/97 End: - Due: -

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Phase: N/A Priority: Normal
NCT ID: NCT05471856 Org: User:
Start: 02/24/23 End: 09/13/28 Due: 09/13/29

A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT06631430 Org: User:
Start: 10/30/24 End: 06/12/25 Due: 06/12/26

A Study in Healthy People to Compare 3 Different Formulations of Apremilast Tablets Taken With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT04811573 Org: User:
Start: 03/31/21 End: 08/18/21 Due: 08/18/22

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02173665 Org: User:
Start: 10/31/04 End: - Due: -